|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 31/451 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/14 | (2017.01) | ||
| A61K 47/40 | (2006.01) | ||
| A61K 47/44 | (2017.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 4233850 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23160271.5 |
| Date of filing the European patent application | 2019-11-27 | |
| (97) | Date of publication of the European application | 2023-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-02 |
| (46) | Date of publication of the claims translation | 2025-01-27 |
| (30) | Number | Date | Country code |
| 201862773848 P | 2018-11-30 | US |
| (72) |
LELETI, Manmohan Reddy , US
POWERS, Jay P , US
|
| (73) |
ChemoCentryx, Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kapsulių preparatai |
| CAPSULE FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 7 | 162.00 EUR |
| 2026-11-27 |